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Introduction
============

Anemia is among the most common conditions that affect pregnancies. Anemia in pregnancy has a varied incidence and etiology depending on the geographic location \[[@REF1]\]. The incidence of anemia has been as high as 35-75% in developing countries compared with only 19% in developed countries \[[@REF2]\].

According to guidelines published in the UK in collaboration with the British Society for Haematology (BSH), Obstetric Haematology Group (BSH OHG), and British Committee for Standards in Haematology (BCSH), anemia in pregnancy is defined as the condition where serum hemoglobin (Hb) level is \<11.0 mg/dl in the first trimester, \<10.5 mg/dl in the second and third trimesters, and \<10.0 mg/dl in the postpartum period \[[@REF3]\].

There are several pathologies that cause anemia in pregnancy, including acute and chronic infections, disorders of hemoglobin synthesis, and nutritional deficiencies such as deficiency of vitamin B12, folic acid, and iron. Dietary iron deficiency is the most common cause of anemia in pregnancy \[[@REF4]\]. Irrespective of the etiology, maternal anemia has been associated with increased risks of both maternal and neonatal adverse outcomes. In a study conducted in Israel, maternal anemia was found to increase the risk of cesarean sections (CS) and the need for blood transfusions. The same study also observed that the neonates of anemic women had an increased risk of a low APGAR score \[[@REF5]\]. Other adverse outcomes include preterm delivery \[[@REF6]\], small-for-gestational-age (SGA) (weight below the 10th percentile for the gestational age) \[[@REF7]\], postpartum hemorrhage (PPH), and preeclampsia \[[@REF8],[@REF9]\]. Even though the trends in Pakistani neonates have been studied from several angles \[[@REF10]-[@REF12]\], little attention has been given to maternal outcomes \[[@REF9]\]. Hence, this study was designed to analyze the maternal and neonatal outcomes in women with third-trimester anemia.

Materials and methods
=====================

This was a review of a historical cohort of all patients delivering in the obstetrics and gynecology department of a tertiary care hospital in Pakistan from January 1, 2019 to June 30, 2019. This study was approved by the institutional review board. Only those data records that had at least one record of hemoglobin (Hb) level in the first or second trimester and one in the third trimester were included.

A semi-structured proforma was constructed to record maternal and neonatal information. Patients were divided into two groups based on their Hb level in the third trimester. Women with Hb level of \<10mg/dL were categorized as anemic, and those with Hb level of \>10mg/dL were categorized as non-anemic \[[@REF3]\]. Demographic characteristics including age, body weight, height, smoking status, and parity were recorded. Clinical characteristics including the history of antenatal visits and outcomes of previous pregnancies, iron supplementation status, and Hb level in the first and/or second trimester of current pregnancy were recorded. Pregnancy outcomes were assessed for both the mothers and babies. Maternal outcomes included in the study were gestational hypertension, preeclampsia, eclampsia, antenatal hemorrhage (any bleeding from the genital tract at 24+0 weeks of gestation till before delivery), postpartum hemorrhage (\>500 ml of blood loss during or within 24 hours of delivery), obstruction of labor (OL)/prolonged labor (PL), induction of labor (IOL), blood transfusions, emergency CS/laparotomy, and maternal mortality. Fetal outcomes included fetal distress, low birth weight (LBW) (less than 2,500 grams), SGA, prematurity (childbirth before 37+0 weeks of gestation), neonatal intensive care unit (NICU) admission, stillbirth, and early neonatal death.

Statistical analysis was completed through SPSS version 21.0 for Windows (IBM Corp., Armonk, NY). Categorical data were presented as frequencies and percentages. Continuous data were presented as mean and standard deviation (SD). A chi-square test was performed to analyze the correlation between categorical variables. A p-value of ≤0.05 was considered significant.

Results
=======

There were 622 records included in the analysis. The mean age of the women was 29.4 (±12.5) years. The mean BMI of the women was 29.3 (±6.4) kg/m^2^, and their mean parity was 5 (±3). There were 235 (37.8%) women who were anemic in their third trimester and 387 (62.2%) who were non-anemic. Their baseline characteristics were compared. It showed that anemic women were younger in age, less likely to have a normal body weight, more likely to be active as well as passive smokers, and more likely to be primiparous (Table [1](#TAB1){ref-type="table"}). 

###### Comparison of baseline demographic characteristics of the anemic and non-anemic study population

  -------------------------- ------------------------- ----------------------------- ----------
  Baseline characteristics   Anemic (n = 235; 37.8%)   Non-anemic (n = 387; 62.2%)   P-value
  Maternal age, years                                                                
  Less than 20               93 (39.5%)                102 (26.3%)                   0.002
  20-30                      88 (37.4%)                172 (44.4%)                   
  More than 30               54 (23.0%)                113 (29.2%)                   
  BMI, kg/m^2^                                                                       
  Underweight (\<18.5 kg)    123 (52.3%)               89 (22.9%)                    \<0.0001
  Normal (18.5-24.9 kg)      37 (15.7%)                193 (49.8%)                   
  Overweight (25-29.9 kg)    43 (18.3%)                78 (20.2%)                    
  Obese (\>30 kg)            32 (13.6%)                27 (6.9%)                     
  Smoking status                                                                     
  Active smoker              53 (22.5%)                64 (16.5%)                    \<0.0001
  Passive smoker             201 (85.5%)               156 (40.3%)                   
  Ex-smoker                  19 (8.1%)                 54 (13.9%)                    
  Non-smoker                 163 (69.4%)               269 (69.5%)                   
  Parity                                                                             
  0                          102 (43.4%)               95 (24.5%)                    \<0.0001
  1-3                        56 (23.8%)                126 (32.5%)                   
  4-6                        14 (5.9%)                 75 (19.4%)                    
  More than 7                63 (26.8%)                91 (23.5%)                    
  -------------------------- ------------------------- ----------------------------- ----------

In the anemic group, 52% had been anemic since their first trimester and the percentage increased to 66% in the second trimester as compared to 30% in the first and 20% in the second trimester in the non-anemic group. The mean Hb level of the anemic group was 6.8 (±2.5) mg/dL in the first trimester, 7.3 (±1.8) mg/dL in the second, and 7.2 (±1.3) mg/dL in the third trimester. The mean Hb level of the non-anemic group was 8.1 (±2.7) mg/dL in the first trimester, 8.8 (±2.9) mg/dL in the second, and 8.9 (±1.9) mg/dL in the third trimester. A comparison of the clinical characteristics of both groups was performed, which showed that anemic women had significantly lower Hb values in first and second trimesters, poor compliance to antenatal visits, lower frequency of iron supplementation, and more frequent treatment for iron deficiency (Table [2](#TAB2){ref-type="table"}).

###### Comparison of clinical characteristics of the anemic and non-anemic study population

  ----------------------------------------------------------------------- ------------------------- ----------------------------- ----------------
  Clinical characteristics                                                Anemic (n = 235; 37.8%)   Non-anemic (n = 387; 62.2%)   P-value
  Hemoglobin level in the first trimester, g/dL                                                                                   
  Less than 8                                                             123 (52.3%)               115 (29.7%)                   \<0.0001
  8-10                                                                    82 (34.8%)                145 (37.5%)                   
  More than 10                                                            9 (3.8%)                  100 (25.8%)                   
  Missing                                                                 21 (8.9%)                 27 (6.9%)                      
  Hemoglobin level in the second trimester, g/dL                                                                                  
  Less than 8                                                             155 (65.9%)               78 (20.2%)                    Not applicable
  8-10                                                                    44 (18.7%)                203 (52.4%)                   
  More than 10                                                            0 (0%)                    99 (25.5%)                    
  Missing                                                                 36 (15.3%)                7 (1.8%)                      
  Iron supplements taken                                                                                                          
  In current pregnancy                                                    68 (28.9%)                128 (33.1%)                   \<0.0001
  In previous pregnancies                                                 103 (43.8%)               235 (60.7%)                   
  Never during pregnancy                                                  64 (27.2%)                24 (6.2%)                     
  Intravenous iron replacement                                                                                                    
  In current pregnancy                                                    104 (44.3%)               21 (5.4%)                     \<0.0001
  In previous pregnancies                                                 115 (48.9%)               66 (17.1%)                    
  Never during pregnancy                                                  29 (12.3%)                300 (77.5%)                   
  Antenatal visits in previous pregnancies (not valid for primigravida)                                                           
  None                                                                    53/133 (39.8%)            33/292 (11.3%)                \<0.0001
  One only                                                                58/133 (43.6%)            101/292 (34.5%)               
  More than one                                                           22/133 (16.5%)            158/292 (54.1%)               
  Outcome of previous pregnancies (not valid for primigravida)                                                                    
  Alive and healthy                                                       103/133 (77.4%)           279/292 (95.5%)               \<0.0001
  Abortion/fetal death/stillbirth                                         21/133 (15.8%)            10/292 (3.4%)                 
  Neonatal/early-childhood death                                          9/133 (6.8%)              3/292 (1.0%)                  
  ----------------------------------------------------------------------- ------------------------- ----------------------------- ----------------

Maternal and neonatal outcomes were compared. In the anemic women group, pregnancy-related complications including gestational hypertension, preeclampsia, eclampsia, antepartum, and postpartum hemorrhage were more common. There was a higher frequency of obstructed/prolonged labor and fetal distress leading to induction and/or emergency CS/laparotomy in the anemic group. The neonatal outcome was also poor in the anemic group. There were no maternal mortalities in our study. There were 29 (4.7%) neonatal deaths, out of which 21 (3.4%) pertained to anemic mothers (Table [3](#TAB3){ref-type="table"}).

###### Comparison of maternal and neonatal outcomes of the anemic and non-anemic study population

NICU: Neonatal intensive care unit

  ---------------------------------------------------------------------------------------------- ------------------------- ----------------------------- ----------------
  Pregnancy outcomes                                                                             Anemic (n = 235; 37.8%)   Non-anemic (n = 387; 62.2%)   P-value
  Gestational hypertension                                                                       131 (55.7%)               103 (26.6%)                   \<0.000
  Preeclampsia                                                                                   153 (65.1%)               98 (25.3%)                    \<0.000
  Eclampsia                                                                                      5 (2.1%)                  0 (0%)                        Not applicable
  Antepartum hemorrhage                                                                          76 (32.3%)                73 (18.8%)                    0.0001
  Postpartum hemorrhage (\>500 ml)                                                               185 (78.7%)               107 (27.6%)                   \<0.000
  Major obstetric hemorrhage (\>2,000 ml)                                                        58 (24.7%)                12 (3.1%)                     \<0.000
  Need for blood transfusion during/within 24 hours of delivery                                  221 (94.0%)               19 (4.9%)                     \<0.000
  Prolonged/obstructed labor                                                                     115 (48.9%)               76 (19.6%)                    \<0.000
  Need of urgent laparotomy due to uncontrollable bleeding                                       12 (5.1%)                 0 (0%)                        Not applicable
  Need of urgent induction of labor due to maternal/fetal distress                               56 (23.8%)                8 (2.1%)                      \<0.000
  Need of urgent caesarean section due to fetal distress/prolonged labor/failure of induction    105 (44.6%)               113 (29.2%)                   0.0001
  Low birth weight (\<2,500 g)                                                                   138 (58.7%)               114 (29.5%)                   \<0.000
  Very low birth weight (\<1,500 g)                                                              78 (33.2%)                13 (3.3%)                     \<0.000
  Small-for-gestational-age                                                                      173 (73.6%)               89 (22.9%)                    \<0.000
  Preterm delivery                                                                               93 (39.5%)                58 (14.9%)                    \<0.000
  Stillbirth                                                                                     18 (7.6%)                 12 (3.1%)                     0.01
  Early neonatal death (within 24 hours)                                                         21 (8.9%)                 8 (2.1%)                      0.000
  NICU admission                                                                                 135 (57.4%)               94 (24.3%)                    \<0.000
  ---------------------------------------------------------------------------------------------- ------------------------- ----------------------------- ----------------

Discussion
==========

Maternal anemia is a common problem encountered by gynecologists and obstetricians worldwide, especially in developing countries. In this study, we found an association between anemia in pregnancy and adverse maternal and neonatal outcomes. While this study throws light on the issue in a developing country, its results cannot be generalized as it was based on cases at a single facility. It lacks demographic diversity, and there is a high probability of missing/incomplete data due to its retrospective nature.

Other studies have shown similar results to ours. Nair et al. studied a large retrospective cohort from India in which 35% of pregnant women had moderate-to-severe anemia. This study reported that anemic women had a nine times higher risk of PPH. For anemic women who underwent an IOL, the risk increased 17-fold; and for anemic women with infections, it increased 19-fold. Adverse neonatal outcomes associated with anemia were LBW, SGA, and perinatal death \[[@REF13]\]. SGA, LBW, and preterm delivery have been reported in other studies from India as well \[[@REF9],[@REF14]\]. Parks et al. also reported a significant association between severe anemia and PPH and neonatal mortality, but no connection between severe anemia and maternal mortality was observed \[[@REF9]\].

The trends from other developing countries such as Sudan, Tanzania, and Bangladesh have not been very different either \[[@REF13]-[@REF20]\]. Neonatal adverse outcomes associated with maternal anemia in these countries include low placental weight, LBW/very LBW, poor APGAR score, SGA, birth asphyxia, fetal anemia, stillbirth, and preterm delivery \[[@REF13]-[@REF20]\]. Maternal adverse outcomes reported in the literature include preeclampsia, PPH, CS delivery, and infections \[[@REF19],[@REF9],[@REF21]\].

Although the incidence of nutritional anemia in pregnancy is low and is in a further decline in developed countries, it is still associated with poor maternal outcomes \[[@REF22]\]. In a Scottish retrospective cohort, maternal anemia reportedly increased the risk of antepartum hemorrhage, severe obstetric hemorrhage, the need for blood transfusion, postpartum infection, and maternal death \[[@REF22]\]. Among Finnish multiparous women, antenatal anemia was associated with preterm delivery, SGA, and NICU admission \[[@REF23]\]. Demuth et al. reported that less than half of the German women diagnosed with iron-deficiency anemia were taking a therapeutic dose of supplemental iron during their pregnancy \[[@REF24]\].

Currently, the management of labor and delivery in women with moderate-to-severe anemia is not governed by any standard guidelines \[[@REF25],[@REF26]\]. The frequency of anemia in the last trimester is on the higher side (38%) as reported in this study. It carries a high risk of poor maternal and fetal outcomes. There is an urgent need to find more evidence and design high-quality protocols on adequate management of women with moderate-to-severe anemia during labor, delivery, and the postpartum period. We believe this study has highlighted the incidence and consequences of antenatal anemia among Pakistani women. There is evidently a pressing need to address maternal nutrition and the general health of women of childbearing age. The need for more interventional studies that can include larger samples at an epidemiological level and anemias of various etiologies cannot be overstated. Studies must be undertaken to assess the value of treating anemia as an independent risk factor in predicting the outcome of pregnancy. There should be an increased focus on improving awareness about the positive impact of adequate micronutrient replenishment on the health of the mother as well as the newborn.

Conclusions
===========

Maternal anemia is associated with adverse maternal and neonatal outcomes. It is important to identify women at risk and ensure that sufficient and timely care is provided. Awareness campaigns must be conducted to educate women about the need to take care of their health and well-being during pregnancy in order for them to have healthy babies. The focus should be placed on proper and adequate maternal nutrition, and women must be urged to seek antenatal care on a regular basis. Appropriate antenatal care will help reduce adverse preventable outcomes such as third-trimester anemia. Awareness campaigns should not be confined to pregnant women, and all women of childbearing age must be educated about the importance of adequate maternal nutrition.
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